Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

UQ1:GR

24.220 EUR 0.014 0.06%

As of 10:45:22 ET on 04/24/2015.

Snapshot for uniQure B.V. (UQ1)

Open: 24.871 Day's Range: 23.954 - 25.070 Volume: 590
Previous Close: 24.206 52wk Range: 6.266 - 32.509 1-Yr Rtn: +232.33%

Stock Chart for UQ1

No chart data available.
  • UQ1:GR 24.220
  • 1D
  • 1M
  • 1Y
24.206
Interactive UQ1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for UQ1

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2015) -1.1630
Est. PEG Ratio -
Market Cap (M EUR) 519.04
Shares Outstanding (M) 21.43
30 Day Average Volume 1,536
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 06/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for UQ1

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for UQ1

UNIQURE B.V. develops gene therapy products that offer the prospect of long-term and potentially curative benefit to patients with genetic or acquired diseases by directing the expression of a therapeutic protein or restoring the expression of a missing protein through a single administration.

Jorn AldagCEO/Member-Mgmt BoardMatthew C KapustaChief Financial Officer
Eric GoossensChief Operating OfficerHans PreustingChief Business Officer
More Company Profile & Key Executives for UQ1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil